Literature DB >> 12642629

Expression of the matricellular protein SPARC in murine lens: SPARC is necessary for the structural integrity of the capsular basement membrane.

Qi Yan1, David Blake, John I Clark, E Helene Sage.   

Abstract

SPARC (Secreted Protein, Acidic and Rich in Cysteine) is a matricellular glycoprotein that modulates cell proliferation, adhesion, migration, and extracellular matrix (ECM) production. Although SPARC is generally abundant in embryonic tissues and is diminished in adults, we have found that the expression of SPARC in murine lens persists throughout embryogenesis and adulthood. Our previous studies showed that targeted ablation of the SPARC gene in mice results in cataract formation, a pathology attributed partially to an abnormal lens capsule. Here we provide evidence that SPARC is not a structural component of the lens capsule. In contrast, SPARC is abundant in lens epithelial cells, and newly differentiated fiber cells, with stable expression in wild-type mice up to 2 years of age. Pertubation of the lens capsule in animals lacking SPARC appears to be a consequence of the invasion of the lens cells situated beneath the capsule. Immunoreactivity for SPARC in the lens cells was uneven, with minimal reactivity in the epithelial cells immediately anterior to the equator. These epithelial cells appeared essentially noninvasive in SPARC-null mice, in comparison to the centrally located anterior epithelial cells, in which strong labeling by anti-SPARC IgG was observed. The posterior lens fibers exhibited cytoplasmic extensions into the posterior lens capsule, which was severely damaged in SPARC-null lenses. The expression of SPARC in wild-type lens cells, together with the abnormal lens capsule in SPARC-null mice, indicated that the structural integrity of the lens capsule is dependent on the matricellular protein SPARC. The effects of SPARC in the lens appear to involve regulation of lens epithelial and fiber cell morphology and functions rather than deposition as a structural component of the lens capsule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642629     DOI: 10.1177/002215540305100412

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.

Authors:  Neveen Said; Kouros Motamed
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 2.  Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma.

Authors:  Joanne E Murphy-Ullrich
Journal:  Front Cell Dev Biol       Date:  2022-05-27

3.  Absence of SPARC leads to impaired lens circulation.

Authors:  Teri M S Greiling; Brad Stone; John I Clark
Journal:  Exp Eye Res       Date:  2009-05-03       Impact factor: 3.467

4.  The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase.

Authors:  Matt S Weaver; Gail Workman; E Helene Sage
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

Review 5.  The lens capsule.

Authors:  Brian P Danysh; Melinda K Duncan
Journal:  Exp Eye Res       Date:  2008-08-16       Impact factor: 3.467

6.  The transcriptome of metamorphosing flatfish.

Authors:  Ricardo N Alves; Ana S Gomes; Kurt Stueber; Mbaye Tine; M A S Thorne; H Smáradóttir; Richard Reinhard; M S Clark; Ivar Rønnestad; Deborah M Power
Journal:  BMC Genomics       Date:  2016-05-27       Impact factor: 3.969

7.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

8.  Expression of integrin-linked kinase in the murine lens is consistent with its role in epithelial-mesenchymal transition of lens epithelial cells in vitro.

Authors:  Matt S Weaver; Natalie Toida; E Helene Sage
Journal:  Mol Vis       Date:  2007-05-14       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.